Priyanga Dharmaratne

Highly accomplished professional with a Ph.D. in Medicinal Chemistry and extensive experience in the pharmaceutical industry. Proficient in navigating EU regulatory requirements, safety standards, and compliance protocols to ensure product safety and regulatory adherence. Demonstrated ability to quickly adapt and excel in fast-paced environments, fostering teamwork and driving results. Adept in pharmacovigilance and regulatory affairs, poised to make a substantial impact in the advancement of healthcare solutions.

• Completed training in Good Manufacturing Practice (GMP) and GxP standards
• Successfully completed Pharmacovigilance 3 - Pv Audit training through White Hall
• Completed Pharmacovigilance 2 training on Global Regulatory Requirements through White Hall

Yang L, Dharmaratne P, Zhu C, Sapugahawatte DN, Rahman N, Barua N, Li C, Kin On Kwok, Luo M, Liyanapathirana V, Ip M. Global epidemiology of asymptomatic colonization of methicillin-resistant Staphylococcus aureus in the upper respiratory tract of young children: a systematic review and meta-analysis. Archives of Disease in Childhood. 2024. 10.1136/archdischild-2023-326124.

Rita WY Ng, Dharmaratne P, Wong S, Hawkey P, Chan PC, Ip M. Revisiting the donor screening protocol of fecal microbiota transplantation (FMT): a systematic review. Gut. 2023; doi: 10.1136/gutjnl-2023-329515

BCL Chan+, Dharmaratne P+, Wang B, KM Lau, CC Lee, DWS Cheung, JYW Chan, GGL Yue, CBS Lau, CK Wong, KP Fung, M Ip. Hypericin and Pheophorbide a Mediated Photodynamic Therapy Fighting MRSA Wound Infections: A Translational Study from In Vitro to In Vivo. Pharmaceutics, 2021, 13, 1399.

Dharmaratne P, Rahman N, Leung A, Ip M. Is there a role of fecal microbiota transplantation in reducing antibiotic resistance burden in gut? A systematic review and meta-analysis. Annals of Medicine. 2021, 53, 661-682

Dharmaratne P, Ligang Yu., Wong, RC, Chan BCL, Lau KM, Clara BS Lau CBS , Ng DKP , Fung KP, Ip M. A Novel Dicationic Boron Dipyrromethene-based photosensitizer for antimicrobial photodynamic therapy against methicillin-resistant Staphylococcus aureus: An In vitro and In vivo study. Current Medicinal Chemistry, 2021, 28, 1-12

Dharmaratne P, Wanga B, Wong RC, Chan BCL , Lau KM , Clara BS Lau CBS , Ng DKP , Fung KP, Ip M. Monosubstituted tricationic Zn(II) phthalocyanine enhances antimicrobial photodynamic inactivation (aPDI) of methicillin-resistant Staphylococcus aureus (MRSA) and cytotoxicity evaluation for topical applications: in vitro and in vivo study. Emerging Microbes and Infections. 2020, 9: 1628-1636.